Project Number:

852

Wyeth BioPharma

SERVICE:

Studies and Permitting for Biotech Facility

DESCRIPTION:

Wyeth BioPharma (formerly Genetics Institute) is a division of Wyeth that focuses on developing recombinant protein biopharmaceuticals. Wyeth retained Tech Environmental to calculate batch process and fugitive emissions from operations at its Andover, Massachusetts facility, including laboratory emissions and emissions from ethanol used for compliance with FDA Good Manufacturing Practices (GMP).


In response to concerns raised by MassDEP regarding volatization of chemicals from the facility's wastewater, Tech Environmental used an EPA-approved fate model to demonstrate that such volatization would be negligible. Tech Environmental developed a permitting strategy, revised the facility's emissions statements, and filed a non-major Comprehensive Plan Approval (CPA) application for facility-wide VOC process emissions.

Print   Email

Key Points

  • A biopharmaceutical laboratory required assistance in responding to MassDEP concerns about process emissions.
  • Tech strategically employed EPA-approved models to satisfy regulators' concerns and assisted in permitting.